Search

everythinglearnresearchcommunity

for

Search:↓

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

SOX4 is crucial for the development of melanoma.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Stromal cells in melanoma promote tumor growth and spread.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

A rare case showed basal cell carcinoma and leiomyosarcoma coexisting, needing careful diagnosis and treatment.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Biological therapy boosts the immune system to effectively fight melanoma.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Blocking YAP/TAZ could be a new way to treat skin cancer.